A Phase 3, Double-blind, Randomized Study of BGB 290 versus Placebo as Maintenance Therapy in Patients with Inoperable Locally Advanced or Metastatic Gastric Cancer that Responded to Platinum-based First-line Chemotherapy

Project: Research

NMA HREC Reference Number: HREC/18/MonH/61
NMA SSA Reference Number: SSA/18/MonH/400
Monash Health Ref: RES-18-0000-118A

Status	Active
Effective start/end date	6/05/19 → 5/05/24